Ancora Advisors, LLC Novo Nordisk A S Transaction History

Ancora Advisors, LLC

$4.06 Billion
Q3 2024

A detailed history of Ancora Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Ancora Advisors, LLC holds 2,493 shares of NVO stock, worth $253,637. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,493

Previous 2,168 14.99%

Holding current value

$253,637

Previous $309,000 4.21%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$119.07 - $145.42 $38,697 - $47,261	325 Added 14.99%	2,493 $296,000
Q2 2024 Aug 14, 2024	BUY	$122.71 - $146.91 $7,976 - $9,549	65 Added 3.09%	2,168 $309,000
Q1 2024 May 15, 2024	BUY	$102.11 - $135.92 $18,481 - $24,601	181 Added 9.42%	2,103 $270,000
Q4 2023 Feb 14, 2024	SELL	$87.78 - $105.45 $54,072 - $64,957	-616 Reduced 24.27%	1,922 $198,000
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $115,402 - $253,216	1,269 Added 100.0%	2,538 $230,000
Q1 2023 May 15, 2023	BUY	$132.34 - $159.14 $4,367 - $5,251	33 Added 2.67%	1,269 $201,000
Q3 2022 Nov 14, 2022	BUY	$95.28 - $116.93 $4,764 - $5,846	50 Added 4.22%	1,236 $123,000
Q2 2022 Aug 15, 2022	SELL	$103.24 - $121.81 $8,465 - $9,988	-82 Reduced 6.47%	1,186 $132,000
Q1 2022 May 16, 2022	SELL	$93.1 - $112.54 $41,336 - $49,967	-444 Reduced 25.93%	1,268 $141,000
Q1 2022 May 13, 2022	BUY	$93.1 - $112.54 $41,336 - $49,967	444 Added 35.02%	1,712 $115,000
Q2 2021 Aug 13, 2021	SELL	$67.66 - $84.76 $30,041 - $37,633	-444 Reduced 25.93%	1,268 $106,000
Q1 2021 May 14, 2021	BUY	$67.06 - $75.82 $51,099 - $57,774	762 Added 80.21%	1,712 $115,000
Q4 2020 Feb 12, 2021	SELL	$63.89 - $73.8 $48,811 - $56,383	-764 Reduced 44.57%	950 $66,000
Q3 2020 Nov 13, 2020	BUY	$63.69 - $70.22 $14,776 - $16,291	232 Added 15.65%	1,714 $119,000
Q2 2020 Aug 14, 2020	SELL	$58.54 - $67.94 $1,756 - $2,038	-30 Reduced 1.98%	1,482 $97,000
Q4 2019 Feb 14, 2020	BUY	$49.86 - $58.26 $75,388 - $88,089	1,512 New	1,512 $88,000
Q4 2018 Feb 15, 2019	SELL	$41.54 - $47.25 $83,578 - $95,067	-2,012 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$46.76 - $51.24 $94,081 - $103,094	2,012 New	2,012 $95,000

Others Institutions Holding NVO

# of Institutions

1,948

Shares Held

320M

Call Options Held

5.22M

Put Options Held

6.6M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $230B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ancora Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ancora Advisors, LLC with notifications on news.

Account

Ancora Advisors, LLC Novo Nordisk A S Transaction History